Before and After I was very wary of any kind of weight loss program like this
Patients receiving Wegovy for weight loss through structured, clinician-led programmes often benefit from personalised guidance on diet and lifestyle
Acknowledgments I thank Lily Lu, MD, PhD for her critical comments and David Liu and Erika Liu for their assistance with editing
bariatric procedure volumes declined 11.4% in 2025 reversing a two-decade growth trend as semaglutide and tirzepatide provide comparable weight loss outcomes for class I and class II obesity without surgical risk, recovery time, or nutritional deficiency complications
In agreement, Matt Kaeberlein, PhD, professor of pathology at UW Medicine and CEO of Optispan said: Its disappointing but not particularly surprising that Novo Nordisks trials failed to show a slowing of Alzheimers progression with semaglutide